SMTL ID : 1f5l.1

UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-AMILORIDE COMPLEX

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: H.46, Q.195, G.196, S.198 Ligands: AMR.3 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.196, A:S.198, A:S.198 Salt bridges: A:H.46 SO4.2: 5 residues within 4Å: Chain A: H.95, N.96, T.178, K.180, M.181 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.96, A:N.96 Water bridges: A:N.96 Salt bridges: A:H.95, A:K.180

1 x AMR: 3,5-DIAMINO-N-(AMINOIMINOMETHYL)-6-CHLOROPYRAZINECARBOXAMIDE(Non-covalent)

AMR.3: 13 residues within 4Å: Chain A: D.192, S.193, C.194, Q.195, S.198, V.216, S.217, W.218, G.219, G.221, C.222, G.229 Ligands: SO4.1 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:S.193, A:S.193, A:S.198, A:G.221 Water bridges: A:S.198, A:S.198, A:S.217, A:G.219, A:G.219, A:V.230 Salt bridges: A:D.192

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zeslawska, E. et al., Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design. J.Mol.Biol. (2000)

Release Date

2001-06-15

Peptides

UROKINASE-TYPE PLASMINOGEN ACTIVATOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

UROKINASE-TYPE PLASMINOGEN ACTIVATOR

Related Entries With Identical Sequence